Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
06/2009
06/11/2009WO2009070910A2 Carboxamide derivatieves having cooling properties
06/11/2009WO2009053128A3 Method for amidating of nitrile in the presence of sulfuric acid
06/11/2009US20090149674 continuous production of alkyl amino acryl amides by reacting alkyl acrylates with high-boiling amines; process achieves hitherto unobtainable product qualities; continuous aminolysis of butyl acrylate, for example
06/11/2009US20090149510 Compositions and methods for modulating a kinase cascade
06/11/2009US20090149445 Tricyclic steroid hormone nuclear receptor modulators
06/10/2009EP2067769A1 Process for producing optically active beta-hydroxy-alpha-aminocarboxylic acid ester
06/10/2009EP1844001B1 Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
06/10/2009EP1532105B1 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof
06/10/2009CN101450909A Segregation and fractionation regeneration method of dimethylformamide as extracting solvent for cracking carbon 5
06/10/2009CN100497501C Phase change inks containing branched triamides
06/10/2009CN100497299C Asymmetric catalytic hydrogenation process of synthesizing serial (2S,3R)-2 benzoyl aminomethyl-3-hydroxy butyrate compounds
06/09/2009US7544839 N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide; nervous system disorders; melatoninergic system disorders; industrial synthesis
06/09/2009US7544835 Carboxylic acid derivative and salt thereof
06/09/2009US7544834 Methods for producing nateglinide B-type crystals
06/09/2009US7544717 2-amino- and 2-thio- substituted 1,3-diaminopropanes
06/09/2009US7544699 Aryl and heteroaryl compounds, compositions, and methods of use
06/09/2009CA2251331C Calcilytic compounds
06/04/2009WO2009067856A1 Histone deacetylase inhibitor, composition and use thereof
06/04/2009WO2009030887A3 Bis-aromatic compounds useful in the treatment of inflammation
06/04/2009WO2007113644A3 New hdac inhibitors
06/04/2009US20090143622 Method For The Synthesis Of Substituted Formylamines And Substituted Amines
06/04/2009US20090143621 Method of Forming Alkoxylated Fluoroalcohols
06/04/2009US20090143583 Transfection reagents
06/04/2009US20090143471 Process for the Atomization of Ioxilan
06/04/2009US20090143469 Salts of nateglinide
06/04/2009US20090143445 HDAC Inhibitors
06/04/2009US20090143374 Use of Compounds and Compositions for the Treatment of Amyloid Diseases
06/04/2009US20090143228 Dioxazine-and Oxadiazine-Substitude Arylamide
06/04/2009US20090142264 18F-Labeled Phenoxyphenyl Nu-benzyl Alkanamid Derivatives for Positron Emission Tomography (PET) Imaging of Peripheral Benzodiazepine Receptor
06/04/2009US20090139433 Dental materials based on alkylenediamine-n,n,n',n'- tetraacetic acid- (meth)acrylamides
06/03/2009EP2065363A1 Dental materials based on alkylenediamine-N,N,N',N'-tetraacetic acid-(meth)acrylamides
06/03/2009EP2064959A1 Aromatic Neomenthylamides as flavouring agents
06/03/2009EP2064176A1 Phenyloxyaniline derivatives
06/03/2009EP2064172A1 A process for producing [(4,4- dif luorocyclohexyl) methyl] amine
06/03/2009EP1487781B8 Process for preparing 2-aminoindan derivatives
06/03/2009CN101445467A Chemical synthesis method of N-(4-chlorobenzoyl)-tyramine
06/03/2009CN101445466A Method for purifying 2, 2-dimethyl-cyclopropane carboxamide produced by biocatalytic method
06/03/2009CN101445463A Beta2-adrenergic receptor agonists
06/03/2009CN101444496A Compounds for the treatment of metabolic disorders
06/03/2009CN100494168C Diamine compound for resisting hepatitis B virus and its preparation method and its application
06/03/2009CN100494167C Anti-hepatitis B virus tertiary amine oxide and preparation method and uses for manufacturing same
06/02/2009US7541495 para-alkyl-substituted N-(4-hydroxy-3-methoxy-benzyl)-cinnamamides, pharmaceutical compositions and uses thereof
06/02/2009US7541494 Process for the manufacture of iohexol
06/02/2009US7541383 Use of carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer; treatment of asthma, allergic diseases and immunologic diseases
05/2009
05/28/2009WO2009066072A2 Inhibitors of 17beta-hydroxysteroid dehydrogenase
05/28/2009WO2009065530A2 Method for producing acylglycinates
05/28/2009WO2009065406A2 Novel cyclic hydrocarbon compounds for the treatment of diseases
05/28/2009WO2009046461A3 Additive useful for stabilizing crude oil
05/28/2009US20090137837 Methods of synthesizing cinacalcet and salts thereof
05/28/2009US20090137420 Methods, compounds and compositions with genotype selective anticancer activity
05/28/2009DE102007055265A1 Verfahren zur Herstellung von Acylglycinaten A process for preparing acylglycinates
05/28/2009CA2706076A1 Novel cyclic hydrocarbon compounds for the treatment of diseases
05/28/2009CA2703893A1 Compound
05/27/2009EP2061760A1 Benzo-fused compounds for use in treating metabolic disorders
05/27/2009EP2061751A1 Nitrate esters of aminoalcohols
05/27/2009EP2061749A1 Positively charged water-soluble prodrugs of acetaminophen and related compounds with very fast skin penetration rate
05/27/2009EP2061737A1 Process for preparing acylglycinates by means of direct oxidation
05/27/2009EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators
05/27/2009CN101443007A TEREPHTHALAMATE compounds and compositions, and their use as HIV integrase inhibitors
05/27/2009CN101440043A N-acyl-alpha-aryl amino acid and preparation thereof
05/27/2009CN101440042A Preparation of N-carbamylglutamic
05/27/2009CN100491342C Crystalline beta2 adrenergic receptor agonist
05/27/2009CN100490799C Compounds, particularly of urea derivatives or ester derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases
05/26/2009US7538247 Catalytic dehydration and amidation of alpha or beta hydroxycarboxylic acids; efficient, simple, mild reaction conditions; water tolerance
05/26/2009US7538241 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression
05/26/2009US7538141 N-benzyl-2-{3-[2-({2-hydroxy-2-[5-hydroxy-6-(hydroxymethyl)pyridin-2-yl]ethyl}amino)-2-methylpropyl]phenyl}acetamide; beta 2 adrenergic receptors agonist; antiinflammatory, antiallergent, respiratory system disorder; side effect reduction; pharmacokinetics, potency, selectivity, duration of action
05/26/2009US7538127 phenethanolamine derivatives like 1-(4-amino-3,5-dichlorophenyl)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]ethanol; respiratory diseases like bronchial asthma; selective stimulant of beta 2-adrenoreceptors; reductive amination; alkylation
05/26/2009US7538124 N-(p-(2-alpha-carboxybenzylamino)ethylamino)phenyl)p-(p-trifluoromethylphenyl)benzamide; hyperlipidemia; antiobesity and anti-type II diabetic agents; Microsomal triglyceride transfer protein inhibitors
05/26/2009CA2344058C Diaminopropionic acid derivatives
05/22/2009WO2009046192A3 Additive useful for stabilizing fuel oils
05/22/2009WO2007095584A3 Histone Deacetylase Inhibitors
05/21/2009US20090131719 Process for the synthesis of (7-methoxy-1-naphthyl) acetonitrile and its application in the synthesis of agomelatine
05/21/2009US20090131675 Methods for structural analysis of proteins
05/21/2009US20090131674 Reaction product of polyamide-forming monomers additionally reacted with a monofunctional element such as stearic acid, and having basic groups such as magnesium salts of carboxylic acid; use as process aids in plastic formulations, as masterbatch carriers, binding resins for metals, ceramic; nonvolatile
05/21/2009US20090131530 4- (or 5-) substituted catechol derivatives
05/21/2009US20090131434 such as E-4-[(2-methyl-2-{[4-(trifluoromethyl)benzyl]oxy}propanoyl)amino]adamantane-1-carboxamide, used for the treatment of non-insulin dependent diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, dementia, psychosis, depression or anxiety
05/21/2009US20090130752 Biodegradable poly(disulfide amine)s for gene delivery
05/20/2009EP2060589A2 Polymeric Photoinitiators
05/20/2009EP2059499A1 Processes of preparing asymmetric dinitrobenzamide mustard compounds, intermediate compounds useful therein and products obtained therefrom
05/20/2009EP2059498A2 Treatment of cancer
05/20/2009EP2059496A1 Acetylenic compounds
05/20/2009EP1562575B1 Fused cycloalkyl amides and acids and their therapeutic applications for the treatment of i.a. epilepsy
05/20/2009CN101437804A Dibenzyl amine compounds and derivatives
05/20/2009CN101434556A Regeneration method of C5 fraction extracting solvent N,N-dimethylformamide
05/20/2009CN100488932C Diphenylether compound, its preparation and use
05/19/2009US7534915 Non-symmetrical gelling agent
05/19/2009US7534913 Crystalline form of nateglinide
05/19/2009US7534894 2-[(4'-{[5-(2-chlorophenyl)-2-(trifluoromethyl)-3-furoyl]amino}-1,1'-biphenyl-3-yl)oxy]-3-phenylpropanoic acid ; thrombosis, atrial fibrillation, pulmonary fibrosis, stroke, myocardial ischemia, atherosclerotic plaque formation, chronic obstructive pulmonary disease, or renal fibrosis
05/19/2009US7534751 3-(2-hydroxyphenyl)-2-propenamides that react to form a lactone and an amine; laundry detergents, perfumes, shampoos and hair conditioners
05/19/2009CA2211381C Compounds with growth hormone releasing properties
05/19/2009CA2192268C Amino alcohol derivative and method for preparing the same
05/14/2009WO2009060882A1 Amide compound and bacterial disease control agent for agricultural and horticultural use
05/14/2009WO2009060843A1 Amidation catalyst, method for producing carboxylic acid amide, and method for producing peptide
05/14/2009US20090124820 C1-Symmetric Bisphospine Ligands and Their Use in the Asymmetric Synthesis of Pregabalin
05/14/2009US20090124698 Selective estrogen receptor modulator compositions and methods for treatment of disease
05/13/2009EP2058297A1 Use of alkamides for masking an unpleasant flavor
05/13/2009EP2058296A1 New crystalline form VI of agomelatine, method of preparation and pharmaceutical compositions thereof
05/13/2009EP2057115A1 4-substituted phenoxyphenylacetic acid derivatives
05/13/2009EP1763505B1 Physiological cooling compositions containing highly purified ethyl ester of n-[[5-methyl-2-(1-methylethyl)cyclohexyl]carbonyl]glycine
05/13/2009CN101429135A Brnsted acid compound containing amide group, preparation and uses thereof
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 289